Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MELE Setting: You are a district nurse who has been involved with Mele’s daughter, Siu and her children. This came about whilst you were caring for Mele’s granddaughter, Fai who has Rheumatic Fever. Siu’s oldest daughter, Maggie has brought home a slip for permission to have the Gardasil vaccination. Siu does not know what Gardisal is.When you visit to give Fai her injection, Siu asks you “what is Gardisal and is this a good thing?” Action point Outline the information that Siu needs to know to be able to make an informed decision. Free Immunisation Immunisation is free for girls aged 9 up to those born on or after 1 January 1990. All girls aged 9 up to those born on or after 1 January 1990 will be offered free immunisation through a doctor, medical clinic or a school based programme. GARDASIL Gardasil helps to protect against the types of HPV that cause the majority of cervical cancer and genital warts. GARDASIL has been clinically tested to be 99-100% effective in preventing cervical cancer, pre-cancers and genital warts caused by the four HPV types in the vaccine. GARDASIL works by causing the body to produce its own protection (antibodies) against HPV. GARDASIL protects against 70% of cervical cancers1 and 90% of genital warts.2 You can not get a HPV infection or develop HPV related disease from GARDASIL. GARDASIL is indicated for girls and women 9 - 45 years. GARDASIL is given to you through a series of three shots in the upper arm over a six-month period.It is very important that you get all 3 shots to get the full protection from the immunisation. GARDASIL has been tested on over 20,000 women world-wide, including New Zealand, and was well tolerated. The most common patient complaints are skin reactions to the injection: soreness, redness, swelling and in some cases fever. For the most part these reactions have been mild. They usually improve or disappear within a few days. You cannot develop an HPV infection or HPV related disease from GARDASIL because the vaccine does not contain the complete virus. GARDASIL is a prescription medicine, and can be administered by either your doctor or nurse. GARDASIL is free for girls aged 9 up to those born on or after 1 January 1990. If you are not eligible for free immunisation but would like the vaccine you can get it through your doctor and you will need to pay approximately $165 per dose for each of the three shots, plus administration and medical fees. The price does vary from doctor to doctor. Human Papillomavirus (HPV) HPV is a common virus. Most people will become infected with HPV in their lifetime. It is not known how much condoms protect against HPV. The HPV virus lives in certain areas of the skin that aren't always protected by condoms, so even if you are careful you can still catch the virus. Women who have one or more types of HPV will still be protected against the HPV types they have not yet been exposed to that are in GARDASIL. Talk to your doctor or nurse for more information. HPV clears up on its own and the cervix cells go back to normal. But for some women, HPV does not go away and the cervix cells continue to change. This can lead to serious problems like high-grade abnormalities and cervical cancer. GARDASIL works best when given before a person has become infected with certain types of HPV, but may also be of benefit if you or your daughter, have had a previous HPV infection. GARDASIL can be helpful in preventing any future HPV infections even if you have already had an abnormal cervical smear test result. Talk to your doctor or nurse for more information. For most women, HPV infection clears up on its own. However, for some women infected with HPV, the virus can result in the development of abnormalities and precancerous cells. Cervical abnormalities can be detected by a cervical smear test. Certain types of HPV, the ones that cause cervical cancer, are also referred to as "high risk" types. Cervical Cancer What is cervical cancer? Cervical cancer is a serious condition that can affect women of all ages. Cervical cancer is the cancer of the cervix, the lower part of the uterus that connects to the vagina. Cervical cancer develops when abnormal cells in the cervix lining multiply following a viral infection. GARDASIL helps prevent cervical cancer by immunising against the types of HPV that cause most cervical cancers. To prevent cervical cancer caused by other types of HPV, women must also have regular pap tests. These screening tests detect early cell changes in the cervix (called ‘precancers'), so that if required, they can be treated before the changes become cancerous. Action point Discuss the aetiology of cervical cancer Cervical cancer is cancer of the cervix, which is the lower part of the uterus or womb. Cervical cancer develops slowly over time, usually taking many years, when abnormal cells grow on the cervix. These abnormal cells are caused by infection with high-risk types of HPV. Abnormalities in the cells of the cervix can be detected by cervical screening and removed. Each year there are around 25,000 abnormal smear test results among New Zealand women. Without cervical screening about one out of 90 women will develop cervical cancer and one out of 200 will die from it. With screening about one out of 570 will develop cervical cancer and one out of 1,280 will die from it. Regular three-yearly cervical smear tests are recommended for all women aged 20 to 70 who have ever been sexually active. There are two main types of cervical cancer. Squamous cell carcinoma, the most common type of cervical cancer, starts in the squamous or skin-like cells, which cover the outer surface of the cervix at the top of the vagina. Adenocarcinoma is a less common type of cervical cancer. It starts in the glandular cells, in the cervical canal. Cervical cancer may be microinvasive or invasive. Microinvasive cervical cancer: This is when cancer cells have just broken through the bottom layer of the skin of the cervix. Invasive cervical cancer: Cancer cells have spread from the surface skin of the cervix into the deeper tissues of the cervix. The cancer may also have spread to part of the vagina, lymph nodes or other tissues. How common is cervical cancer? In New Zealand, about 150 women are diagnosed with cervical cancer each year. Signs and symptoms of cervical cancer Early changes in the cells of the cervix don’t usually cause symptoms, which is why doctors encourage women to have regular cervical smear tests. If early cell changes develop into cervical cancer, the most common signs include: • • • vaginal bleeding between periods bleeding after intercourse pain during intercourse • • • • • unusual vaginal discharge vaginal bleeding after menopause excessive tiredness leg pain or swelling low back pain. All these symptoms are common to many conditions and may not mean you have cervical cancer. However, if you have these symptoms, have them checked by your doctor. Causes of cervical cancer Some factors seem to put some women at a higher risk of cervical cancer. These risk factors include: • Human Papilloma Virus (HPV). Almost everyone is infected with HPV at some stage in their life. Most cases of HPV resolve (improve) without treatment and have no ill effects. Most women who have HPV do not ever show signs of abnormal cell changes. However, in some women it can cause cell changes that lead to dysplasia. If untreated, they may become cancer. A vaccine has now been developed that prevents the types of HPV most commonly linked to cervical cancer. The vaccine is most beneficial if given to young girls before they are exposed to HPV, that is, before they start having sex. • daughters of women who used the drug diethylstilboestrol (DES) during pregnancy to prevent a miscarriage. The use of this drug has declined since the 1940s and 1950s. • smoking. How long does it take for cervical cancer to develop? Cervical cancer can develop over 10 or more years. Women receiving normal cervical smear test results can already be infected with HPV. A small proportion of women infected with HPV whose immune systems are not clearing the infection are at risk of developing precancerous abnormalities. If these are not detected through cervical screening and treated, they can lead to cervical cancer. Most but not all women with high-grade abnormalities on the cervix will develop cervical cancer if they are not treated. There can be a long interval between being infected with HPV, the development of abnormalities and the development of cancer Action point Discuss the issue of informed decision making and the rights of children. Youth Participation is a right NZ became past of the United Nations Convention on the Rights of the Child (UNCROC) in 1993. UNCROC states that all young people under 18 years of age have the right to participate in decision making. Human Rights NZ 2010 outlines that: Children and young people have the same basic general human rights as adults Have specific human rights that recognise their special need for protection http://www.hrc.co.nz/repor/chapters/chapter04/children01.html#wha http://www.myd.govt.nz/working-with-young-people/youth-participation-in-decision-making/index.html Action point: Identify all the immunisations on the free schedule and eligibility criteria. HPV immunisation programme – New Zealand (2008) – Gardasil Female- age 12 years- school(year 8) From 2011 onwards, the Gardasil vaccine is offered to girls 12 years of age. The vaccine can be obtained through available health centres and GP’s. Given as a course of three injections over a six month period Females aged 12-20 years commence before 20th birthday Females born in 1990 or 1991 Have until 31 December 2011 to start the course Setting: The two oldest girls are starting to rebel against their mother’s restrictions on their social activities. Part of Siu’s concerns around the vaccinations for HPV centres around the church telling them it is a bad thing because it will make the girls more sexually active. Action point How can you help Siu with this problem? What help can she find in the community? Inform Siu that there are available non government agencies which provide information more information on the programme. These are: Family Life Education Pasefika(FLEP) Affirming Women Te Rapakau Health Waikato Pacific Island Health Community Action point If one of the girls did get pregnant, outline her legal rights, citing relevant legislation in detail. If you are undecided about what to do, remember you do have choices You can keep your baby and bring up your baby yourself, hopefully with some great support from friends and family You can continue with your pregnancy and then have your baby adopted by another family You can continue with your pregnancy, but have your baby brought up by another family member. You may decide to terminate your pregnancy (have an abortion). In New Zealand this is legal at any age, with or without your parents’ consent, so long as 2 doctors agree that continuing with your pregnancy would be a danger to your physical or mental health. You are entitled to see another doctor if your own doctor does not agree with abortion. Setting: There is considerable discussion about the fact that the two teenagers in the family have become very conscious of their weight and want to conform to the peer accepted slim image. Mele and her daughter express that this is not ok because then their friends would accuse them of not feeding the children properly. They add that it is their way to be large. Action point How will you respond to these statements? One of the most important elements in Pacific people is their culture. Culture includes how they understand their sickness. Therefore it is vital to treat the client holistically. As nurses we need to learn about Pacific physical needs, for example learning about what is their diet, cultural food and its significance. Education and advice them on the effects of illness cause by healthy eating, ask and dialogue with the patient on the cause of obesity. From a pacific perspective, obese means that you are well fed and well nurture and from the westernised culture it is unhealthy. Therefore, having the knowledge about pacific people’s practises and beliefs will help them to integrate this into planning their cares. Action Point: BMI is usually used to determine if people are overweight or obese. Identify the drawbacks of this system based on ethnic variations. Are you able to identify any other measurements of healthy weight? If so, what are they? Body Fat Testing Target Heart Rate Blood Test Waist Circumference Waist to Hip Ratio Action point Identify members within their own community who may help the family with this problem. Family members Nurses of the same ethnicity, gender- assist in case of language barrier Church members Pacific women’s group Action point Discuss the effects migration has had on the health of Pacific peoples. Culture Language and education Cost Past experiences Cultural Safety Setting: Mele, who is Agnes’s friend and companion, has been persuaded to go to her GP. Agnes and Mele’s daughter have noticed that she has a very nasty smell, even after a shower and is losing weight. The GP finds that Mele has a suppurating mass on her Left Breast. This is strongly indicative of advanced carcinoma. Mele is admitted to hospital but after family conference with the oncologist she is returned home. Action point: Describe the more common types of breast cancer, also identifying when there is a genetic factor. Carcinoma in situ (in SIGH-to): This term is used to describe the early stage of cancer, when it is confined to the place where it originated, typically the ducts or the lobules. It has not yet spread into the fatty tissues in the breast or to other organs in the body. Ductal carcinoma in situ (DCIS): This is the most common type of noninvasive breast cancer and almost all women at this stage can be cured with treatment. DCIS means that the cancer is confined to the ducts and has not spread through the walls into the fatty tissue of the breast. A mammogram is the best way to detect DCIS in its early stage. Lobular carcinoma in situ (LCIS): This is not a true type of cancer; however, having LCIS increases a woman's risk of getting cancer later. It originates in the milk-producing glands but does not go through the wall of the lobules. It is very important that women with LCIS frequently check for signs of breast cancer and follow screening guidelines. Infiltrating (invasive) ductal carcinoma (IDC): This is the most common type of breast cancer. It originates in a milk passage or duct, spreads through the wall of the duct, and invades the fatty tissue of the breast. From there it can spread to other parts of the body. IDC accounts for about 80% of invasive breast cancers. Infiltrating (invasive) lobular carcinoma (ILC): This type of cancer originates in the milk glands or lobules. It can then spread to other parts of the body. ILC accounts for about 10% of invasive breast cancers Only about 5 percent of those patients who develop breast cancer, have will have one or more identifiable genetic risk factor for breast cancer. This means majority of the breast cancers are unrelated to genetic risk factors. However if a woman inherits a genetic mutation like BRCA1 and BRCA2 the lifetime risk of development of breast cancer in that woman may be as high as 85 percent. BRCA1 and BRCA2 mutations may also be associated with increased risk of development of breast cancer at younger age, hence when a young woman develops breast cancer this possibility should be explored especially with other family members affected with breast or ovarian cancer. Both BRCA1 and BRCA2 are inherited as autosomal dominant mode and can be passed to offspring by either paternal or maternal lineage. In the general population the incidence of BRCA1 mutation is between 1 in 500 and 1 in 800. The incidence of BRCA2 mutation is even lower. BRCA1 and BRCA2 are not the only genetic abnormalities that increase risk of breast cancer. Mutations in several other genes have been associated with hereditary breast. These mutations account for only a minor fraction of hereditary breast cancers. The great majority of hereditary breast cancer occurs in carriers of BRCA1 and BRCA2. Overall, it has been estimated that inherited BRCA1 and BRCA2 mutations account for 5 to 10 percent of the total breast cancers. BRCA2 gene is located on chromosome 13. The risk of development of breast cancer in women carrying BRCA2 mutations are BRCA2 gene is located on chromosome 13. The risk of development of breast cancer in women carrying BRCA2 mutations are similar to the risk of BRCA1 carriers, however the risk of development of ovarian cancer is lower in BRCA2 mutation carriers compared to BRCA1 mutation carriers. Men carrying BRCA2 mutation have an increased risk of developing breast cancer and the lifetime risk for a male carrier is about 5 percent. Breast cancer in a male is rare, but when it occurs it may be associated with BRCA2 mutation. BRCA2 mutations may also increase risk of other cancer including pancreatic cancer, stomach cancer, gallbladder and bile duct cancer, and melanoma. Action point: Differentiate between benign and malignant growths Differentiation Nuclear Fission Benign Small shaped,similar shape to original form None or Few Malignant Large shaped, different shape to original form More common and can be seen as pathological nuclear fission Fast Invasive growth and exogenous, which no envelope, and the general surrounding tissue is not clear boundaries, usually can not promote, with the latter every invasive growth Growth Rate Growth Mode Slow expansion of exogenous growth, which often form coated with clear boundaries around the organization in general, it can often push Secondary changes Necrosis, bleeding Frequent bleeding, necrosis, such as the formation of ulcers Movement Recurrence Does not transfer Few post-operative relapse Often transfer After the surgery, such as the treatment of relapsed more Benign Growth Benign tumors are slow growing lesions which remain localized to the site of origin. This means that it does not spread into adjacent tissue. A benign tumor is NOT cancer. There are different types of benign tumors that are named according to the site where it occurs. Epithelial tumors are either papillomas (arising from non-secretory epithelium) or adenomas (arising from secretory epithelium). Mesenchymal and connective tissue tumors are usually named according to the tissue of origin and appended with the suffix ‘oma’. For example lipoma is a benign tumor arising from fat cells of lipid tissue or osteoma from bone tissue. However, there are several exceptions like lymphoma, myeloma which are malignant tumors or tuberculoma which is a lesion in tuberculosis. Characteristics of a Benign Tumor These are slow growing tumors made up of cells that closely resemble the parent cells of the organ or tissue of origin. The benign tumors do not spread to surrounding tissue or to distant sites in the body. The nucleus of the benign tumor cells remains normal and the border of the tumor is well defined or sometimes encapsulated. Some long standing benign tumors may turn malignant eventually. Effects of Benign Tumors Even though benign tumors are confined to its site of origin, it can lead to certain clinical complications. It can cause pressure effects on the adjacent tissues. For example, a benign tumor of the pituitary gland can cause visual disturbances by compressing the optic nerve. A benign tumor can secrete hormones. For example, a benign tumor of the thyroid gland can cause thyrotoxicosis (excess of thyroid hormones) or a gastrinoma (stomach) can secrete gastrin leading to high gastric acid production. Sometimes a benign tumors can transform into malignant tumor (cancer). For example, adenomatous polyps of the colon can progress to adenocarcinoma of colon (colon carcinoma). Benign tumors can physically impede the normal functioning of certain organs. For example, a large lipoma near a joint can interfere with full mobility of the joint while a large fibroid of uterus may interfere with normal labor. Benign tumors can cause some psychological impact – depression due to cosmetic reasons or anxiety because of fear about the tumor turning dangerous. Malignant (Cancerous) Growth Malignant tumors are lesions with uncontrolled growth that invades surrounding tissues and spreads to distant sites. The pattern of growth and invasion is the reason that a malignant tumor or malignancy is known as cancer. Malignant epithelial tumors are called carcinomas like squamous cell carcinoma or adenocarcinoma. Malignant tumors of connective tissue are called sarcomas like liposarcoma, fibrosarcoma or osteosarcoma. Malignancy of the blood is called leukemia and that of lymphoid tissue is known as a lymphoma. Some tumors do not fall into either of the classical groups and are often referred to as borderline tumors. Characteristics of Cancer Malignant tumors are fast growing lesions. The cells resemblance of the parent cells of the organ or tissue of origin is highly variable and often the resemblance is poor. It divides rapidly. The malignant cells have hyperchromatic nucleus with an irregular outline, multiple nucleoli and are pleomorphic. It can invade the surrounding tissue and spread to distant sites (metastases). The border of the malignant tumor is poorly defined or irregular. There may be necrosis or ulceration in the malignant tissue. Effects of Cancer Malignant tumors are extremely harmful, cause significant damage and often leads to death if left untreated. A malignant tumor can compress the adjacent tissue and directly invade the area. It may spread to distant sites and form secondary tumors (metastases). Some cancer can lead to hemorrhage and subsequent blood loss from ulcerated surfaces like colon cancer. Tumors of hollow organs can lead to obstruction of the lumen and affect the movement of substances through these cavities. For example, a malignant tumor of esophagus, stomach or colon can cause obstruction to passage of food and feces. Some malignant tumors also produce hormones like ACTH from certain lung tumors. Cancers usually cause weight loss and debility (cancer cachexia) Cancers are often associated with severe pain in late stages. Malignant tumors tend to cause serious psychological trauma, particularly associated with fear and depression of impending death and recurrence Action point: Identify the three main treatment therapies for neoplasia. The specific treatment of a cancer depends on the type of cancer, its location in the body and how far throughout the body it has spread. There are three main cancer treatments that can help stop or slow the spread of cancer. In chemotherapy, a combination of drugs is used in order to combat the cancer. The drugs used depend on the type of cancer that the patient has. They are sometimes used to shrink tumors so that a doctor can surgically remove them. The drugs in chemotherapy are usually given orally, but they may also be injected. After each chemotherapy session, patients are left to rest for around one week to a month. The drugs can cause some side effects, including hair loss, sickness and mouth sores. Chemotherapy usually lasts a maximum of six sessions. Radiotherapy, another of the three major cancer treatments, attempts to kill the cancer cells with radiation. The radiation is administered by controlled x-rays to the cancer-affected area. The x-rays are administered in a specific way in order not to cause damage to the surrounding tissue. Like all cancer treatments, radiotherapy can cause some side effects, such as depression, lethargy and a lack of appetite. Some women who have radiotherapy in the pelvic region have been known to start menopause early. The last of the major cancer treatments is invasive surgery. If cancer is still in the early stages and has not spread, then surgery is sometimes the best treatment. Surgery is also used if the cancer appears as solid tumors. Some of the surrounding tissue, including some lymph nodes, may also be removed during surgery in order to prevent the cancer from returning. In addition to the three major cancer treatments, a combination of cancer treatments may be advised by an oncologist, a doctor who is trained specifically to diagnose and treat cancer. A combination of the cancer treatments discussed above is known as a multi-modality procedure. If the disease has spread too far for any treatment to be effective, then palliative care will be given to improve the quality of life for the sufferer. Palliative care aims to relieve pain during the remaining lifetime of the sufferer. Cancer treatments are under constant research, and vast amounts of funds and manpower are used to find new cancer treatments every year. Setting: Mele has never had breast screening because she says she didn’t really understand what it did and whether it was painful. She also said she was too shy and embarrassed. Action point: Identify government and non-government initiatives in place to address these issues within the pacific community. Breast Screen Aotearoa provide free mammograms to women age 45-69 National Screening Unit campaign targeting Pacific women and their communities aims to raise awareness about breast screening and increase understanding of the benefits of early detection New Zealand Breast Cancer Foundation Non profit organisation and non government funded charitable trust Provide free nationwide breast health and cancer seminars Education resources